OncoSynergy, Inc.

Congrats @EKNduom 🎉! We are excited to continue collaborating on impactful research with you.

Congrats Chibueze! The entire OncoSynergy team is proud of you!

“There is no limit to what we, as women, can accomplish.” - Michelle Obama Happy International Women's Day from this woman-led company dedicated to treating rare and resistant cancers. #internationalwomensday

- (bottom right) Dr. Edith H. Quimby, a medical physicist, was a pioneer in the therapeutic use of X-rays and radium.

- (bottom left) Dr. Rosalind Franklin was a chemist and X-ray crystallographer whose Photo 51 revealed the double helix of DNA — an essential discovery in understanding DNA.

Trailblazers 💫 #WomensHistoryMonth Pictured: - (top left) Dr. Jane C. Wright is known for promoting chemotherapy as a viable treatment option for patients.

To learn more about Dr. Cooke Wright, visit cfmedicine.nlm.nih.gov/physicians/bio…

🧬 Was the Head of the Cancer Chemotherapy Department and Associate Dean at New York Medical College 🧬 Was the first woman to be elected President of the New York Cancer Society 🧬 Was appointed Head of the Cancer Research Foundation at the age of 33.

February is Black History Month and OncoSynergy would like to celebrate a pioneer in the oncology space - Dr. Jane Cooke Wright. #BHM #BlackHistory #BlackHistoryMonth

Over 40% of cancers occur due to preventable causes ( i.e. poor diet, lack of exercise, smoking, sun overexposure). 🍔🌭🛋️🚬🚭☀️ During #NationalCancerPreventionMonth we urge you to make one lifestyle change that can reduce your cancer risk🎗️

Shout out to the team at @OncoSynergy for this accomplishment and our amazing collaborators at @ChildrensLA, led by Yong Mi Kim, MD, PhD. chla.org/blog/researchl…

When you realize the cancer drug you invented is a platform. 🤎💙

Let us continue to strive towards a hopeful and just world. #MLKDay #MLKJRDAY #mlkjr

"Based on that data from CHLA, the FDA granted OncoSynergy Inc. orphan drug designation for the compound, OS2966, a first-in-class monoclonal antibody that targets a protein called integrin beta-1." Read more about this exciting work to treat #AML here: chla.org/blog/researchl…

Happy New Year from OncoSynergy🧠🎆

#MerryChristmas and Happy Holidays from the #OncoSynergy family to yours🎄💙